IBDEI0BE ; ; 01-AUG-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4)
 ;;=^IBE(358.4,
 ;;^UTILITY(U,$J,358.4,0)
 ;;=IMP/EXP SELECTION GROUP^358.4I^1182^1174
 ;;^UTILITY(U,$J,358.4,1,0)
 ;;=PHYSICIAN TELEPHONE CODES^1^1
 ;;^UTILITY(U,$J,358.4,2,0)
 ;;=NON-PHYSICIAN TELEPHONE CALLS^2^1
 ;;^UTILITY(U,$J,358.4,3,0)
 ;;=SEIZURES/EPILEPSY/SPELLS^1^2
 ;;^UTILITY(U,$J,358.4,4,0)
 ;;=CEREBROVASCULAR DISEASE^2^2
 ;;^UTILITY(U,$J,358.4,5,0)
 ;;=DIZZINESS^3^2
 ;;^UTILITY(U,$J,358.4,6,0)
 ;;=ENCEPHALOPATHY^4^2
 ;;^UTILITY(U,$J,358.4,7,0)
 ;;=HEADACHE^5^2
 ;;^UTILITY(U,$J,358.4,8,0)
 ;;=MOVEMENT DISORDERS^6^2
 ;;^UTILITY(U,$J,358.4,9,0)
 ;;=NEOPLASMS^7^2
 ;;^UTILITY(U,$J,358.4,10,0)
 ;;=NEURODEGENERATIVE DISEASE^8^2
 ;;^UTILITY(U,$J,358.4,11,0)
 ;;=SLEEP DISORDERS^9^2
 ;;^UTILITY(U,$J,358.4,12,0)
 ;;=SPECIAL SCREENING^10^2
 ;;^UTILITY(U,$J,358.4,13,0)
 ;;=OTHER^11^2
 ;;^UTILITY(U,$J,358.4,14,0)
 ;;=BODY  MASS INDEX (BMI)^2^3
 ;;^UTILITY(U,$J,358.4,15,0)
 ;;=COUNSELING^3^3
 ;;^UTILITY(U,$J,358.4,16,0)
 ;;=PREVENTIVE HEALTH ENCOUNTER^1^3
 ;;^UTILITY(U,$J,358.4,17,0)
 ;;=HISTORY OF ILLNESS^4^3
 ;;^UTILITY(U,$J,358.4,18,0)
 ;;=LONG TERM DRUG USE^5^3
 ;;^UTILITY(U,$J,358.4,19,0)
 ;;=OTHER^11^3
 ;;^UTILITY(U,$J,358.4,20,0)
 ;;=SCREENING^6^3
 ;;^UTILITY(U,$J,358.4,21,0)
 ;;=TRANSPLANT^8^3
 ;;^UTILITY(U,$J,358.4,22,0)
 ;;=VACCINATIONS^9^3
 ;;^UTILITY(U,$J,358.4,23,0)
 ;;=WOMEN'S HEALTH^10^3
 ;;^UTILITY(U,$J,358.4,24,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^7^3
 ;;^UTILITY(U,$J,358.4,25,0)
 ;;=IMMUNIZATIONS^4^4
 ;;^UTILITY(U,$J,358.4,26,0)
 ;;=BEHAVIOR CHANGE INTERVENTION,INDIVIDUAL^1^4
 ;;^UTILITY(U,$J,358.4,27,0)
 ;;=COUNSELING RISK FACTOR REDUCTION^2^4
 ;;^UTILITY(U,$J,358.4,28,0)
 ;;=OTH PREVENTIVE MEDICINE SERVICES^5^4
 ;;^UTILITY(U,$J,358.4,29,0)
 ;;=PREVENTIVE MEDICINE,GROUP^8^4
 ;;^UTILITY(U,$J,358.4,30,0)
 ;;=PREVENTIVE HEALTH VISIT-EST PT^6^4
 ;;^UTILITY(U,$J,358.4,31,0)
 ;;=PREVENTIVE HEALTH VISIT-NEW PT^7^4
 ;;^UTILITY(U,$J,358.4,32,0)
 ;;=IMMUNIZATION ADMINISTRATION^3^4
 ;;^UTILITY(U,$J,358.4,33,0)
 ;;=RESPIRATORY^6^5
 ;;^UTILITY(U,$J,358.4,34,0)
 ;;=SLEEP TESTING AND EVAL^7^5
 ;;^UTILITY(U,$J,358.4,35,0)
 ;;=OXIMETRY^4^5
 ;;^UTILITY(U,$J,358.4,36,0)
 ;;=CPAP^1^5
 ;;^UTILITY(U,$J,358.4,37,0)
 ;;=EDUCATION/TRAINING^2^5
 ;;^UTILITY(U,$J,358.4,38,0)
 ;;=PROLONGED CLINICAL STAFF SERVICES^5^5
 ;;^UTILITY(U,$J,358.4,39,0)
 ;;=HOME SLEEP STUDIES^3^5
 ;;^UTILITY(U,$J,358.4,40,0)
 ;;=TELEHEALTH PATIENT SITE^8^5
 ;;^UTILITY(U,$J,358.4,41,0)
 ;;=WIRELESS MONITOR OF PAP DEVICES^9^5
 ;;^UTILITY(U,$J,358.4,42,0)
 ;;=NEW PATIENT^2^6
 ;;^UTILITY(U,$J,358.4,43,0)
 ;;=ESTABLISHED PATIENT^1^6
 ;;^UTILITY(U,$J,358.4,44,0)
 ;;=CONSULTATIONS^3^6
 ;;^UTILITY(U,$J,358.4,45,0)
 ;;=PULMONARY DIAGNOSES^2^7
 ;;^UTILITY(U,$J,358.4,46,0)
 ;;=SLEEP DX PRELIMINARY^3^7
 ;;^UTILITY(U,$J,358.4,47,0)
 ;;=SLEEP DX CONFIRMED^4^7
 ;;^UTILITY(U,$J,358.4,48,0)
 ;;=OTHER SLEEP RELATED DX^6^7
 ;;^UTILITY(U,$J,358.4,49,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^5^7
 ;;^UTILITY(U,$J,358.4,50,0)
 ;;=OBESITY & BMI DX^1^7
 ;;^UTILITY(U,$J,358.4,51,0)
 ;;=SPECIAL SERVICES^10^8
 ;;^UTILITY(U,$J,358.4,52,0)
 ;;=CHEMO NURSE PROCEDURES^2^8
 ;;^UTILITY(U,$J,358.4,53,0)
 ;;=INFUSION DRUGS^7^8
 ;;^UTILITY(U,$J,358.4,54,0)
 ;;=BLOOD PRODUCTS^1^8
 ;;^UTILITY(U,$J,358.4,55,0)
 ;;=DIAGNOSTIC PROCEDURES^3^8
 ;;^UTILITY(U,$J,358.4,56,0)
 ;;=OTHER DRUGS^8^8
 ;;^UTILITY(U,$J,358.4,57,0)
 ;;=IMMUNIZATION ADMINISTRATION^5^8
 ;;^UTILITY(U,$J,358.4,58,0)
 ;;=IMMUNIZATIONS^6^8
 ;;^UTILITY(U,$J,358.4,59,0)
 ;;=PROLONGED SVC-MD/NP/PA^9^8
 ;;^UTILITY(U,$J,358.4,60,0)
 ;;=EDUCATION/TRAINING^4^8
 ;;^UTILITY(U,$J,358.4,61,0)
 ;;=NEW PATIENT^2^9
 ;;^UTILITY(U,$J,358.4,62,0)
 ;;=ESTABLISHED PATIENT^1^9
 ;;^UTILITY(U,$J,358.4,63,0)
 ;;=CONSULTATIONS^3^9
 ;;^UTILITY(U,$J,358.4,64,0)
 ;;=COMPLEX CHRONIC CARE^4^9
 ;;^UTILITY(U,$J,358.4,65,0)
 ;;=ANEMIA^1^10
 ;;^UTILITY(U,$J,358.4,66,0)
 ;;=ARTIFICIAL OPENING STATUS^2^10
 ;;^UTILITY(U,$J,358.4,67,0)
 ;;=BREASTS and GYN NEOPLASMS^3^10
 ;;^UTILITY(U,$J,358.4,68,0)
 ;;=COAGULATION DISORDERS^4^10
 ;;^UTILITY(U,$J,358.4,69,0)
 ;;=COUNSELING AND SCREENING^5^10
 ;;^UTILITY(U,$J,358.4,70,0)
 ;;=GENITOURINARY NEOPLASMS^6^10
 ;;^UTILITY(U,$J,358.4,71,0)
 ;;=GI CANCER^7^10
 ;;^UTILITY(U,$J,358.4,72,0)
 ;;=HEAD NECK AND LUNGS NEOPLASMS^8^10
 ;;^UTILITY(U,$J,358.4,73,0)
 ;;=HEMOGLOBINOPATHIES^9^10
 ;;^UTILITY(U,$J,358.4,74,0)
 ;;=LYMPHOID NEOPLASMS^10^10
 ;;^UTILITY(U,$J,358.4,75,0)
 ;;=METASTATIC SITES^13^10
 ;;^UTILITY(U,$J,358.4,76,0)
 ;;=MALIGNANT NEOPLASMS OF OTHER SITES^11^10
 ;;^UTILITY(U,$J,358.4,77,0)
 ;;=MYELOID NEOPLASMS AND DISORDERS^14^10
 ;;^UTILITY(U,$J,358.4,78,0)
 ;;=NEOPLASM OF UNCERTAIN BEHAVIOR^15^10
 ;;^UTILITY(U,$J,358.4,79,0)
 ;;=NEOPLASM OF UNSPECIFIED NATURE^16^10
 ;;^UTILITY(U,$J,358.4,80,0)
 ;;=PERSONAL HISTORY^19^10
 ;;^UTILITY(U,$J,358.4,81,0)
 ;;=MALNUTRITION^12^10
 ;;^UTILITY(U,$J,358.4,82,0)
 ;;=OTHER^18^10
 ;;^UTILITY(U,$J,358.4,83,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^20^10
 ;;^UTILITY(U,$J,358.4,84,0)
 ;;=ESTABLISHED PATIENT^1^11
 ;;^UTILITY(U,$J,358.4,85,0)
 ;;=CONSULTATIONS/OPINIONS^2^11
 ;;^UTILITY(U,$J,358.4,86,0)
 ;;=NEW PATIENTS^3^11
 ;;^UTILITY(U,$J,358.4,87,0)
 ;;=NEUROLOGY/SEIZURE^7^12
 ;;^UTILITY(U,$J,358.4,88,0)
 ;;=EEG^4^12
 ;;^UTILITY(U,$J,358.4,89,0)
 ;;=SLEEP TESTING^10^12
 ;;^UTILITY(U,$J,358.4,90,0)
 ;;=MUSCLE TESTING/EMG^6^12
 ;;^UTILITY(U,$J,358.4,91,0)
 ;;=EVOKED POTENTIAL^5^12
 ;;^UTILITY(U,$J,358.4,92,0)
 ;;=BIOPSY^2^12
 ;;^UTILITY(U,$J,358.4,93,0)
 ;;=AUTONOMIC FUNCTION TESTS^1^12
 ;;^UTILITY(U,$J,358.4,94,0)
 ;;=STEREOTACTIC^11^12
 ;;^UTILITY(U,$J,358.4,95,0)
 ;;=EDUCATION^3^12
 ;;^UTILITY(U,$J,358.4,96,0)
 ;;=NEUROSTIMULATORS^8^12
 ;;^UTILITY(U,$J,358.4,97,0)
 ;;=PROLONGED SERVICES^9^12
 ;;^UTILITY(U,$J,358.4,98,0)
 ;;=SEIZURES/EPILEPSY/SPELLS^16^13
 ;;^UTILITY(U,$J,358.4,99,0)
 ;;=CEREBROVASCULAR DISEASE^3^13
 ;;^UTILITY(U,$J,358.4,100,0)
 ;;=DIZZINESS^4^13
 ;;^UTILITY(U,$J,358.4,101,0)
 ;;=ENCEPHALOPATHY^6^13
 ;;^UTILITY(U,$J,358.4,102,0)
 ;;=HEADACHE^7^13
 ;;^UTILITY(U,$J,358.4,103,0)
 ;;=MOVEMENT DISORDERS^9^13
 ;;^UTILITY(U,$J,358.4,104,0)
 ;;=NEOPLASMS^11^13
 ;;^UTILITY(U,$J,358.4,105,0)
 ;;=NEURODEGENERATIVE DISEASE^12^13
 ;;^UTILITY(U,$J,358.4,106,0)
 ;;=OTHER^14^13
 ;;^UTILITY(U,$J,358.4,107,0)
 ;;=CARDIAC DISORDERS^2^13
 ;;^UTILITY(U,$J,358.4,108,0)
 ;;=INFLAMMATORY & DEMYELINATING DISEASES^8^13
 ;;^UTILITY(U,$J,358.4,109,0)
 ;;=NEUROMUSCULAR DISORDERS^13^13
 ;;^UTILITY(U,$J,358.4,110,0)
 ;;=PAIN^15^13
 ;;^UTILITY(U,$J,358.4,111,0)
 ;;=SPINAL CONDITIONS^18^13
 ;;^UTILITY(U,$J,358.4,112,0)
 ;;=SYMPTOMS^20^13
 ;;^UTILITY(U,$J,358.4,113,0)
 ;;=VISION DISTURBANCES^21^13
 ;;^UTILITY(U,$J,358.4,114,0)
 ;;=EMG DX^5^13
 ;;^UTILITY(U,$J,358.4,115,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^19^13
 ;;^UTILITY(U,$J,358.4,116,0)
 ;;=MUSCLE ATROPHY^10^13
 ;;^UTILITY(U,$J,358.4,117,0)
 ;;=BOTOX^1^13
 ;;^UTILITY(U,$J,358.4,118,0)
 ;;=SEQUELAE OF CEREBROVASCULAR DISEASE^17^13
 ;;^UTILITY(U,$J,358.4,119,0)
 ;;=ESTABLISHED PATIENT^1^14
 ;;^UTILITY(U,$J,358.4,120,0)
 ;;=CARE PLAN OVERSIGHT^1^15
 ;;^UTILITY(U,$J,358.4,121,0)
 ;;=OTHER SERVICES^4^15
 ;;^UTILITY(U,$J,358.4,122,0)
 ;;=CASE MANAGEMENT^2^15
 ;;^UTILITY(U,$J,358.4,123,0)
 ;;=EDUCATION^3^15
 ;;^UTILITY(U,$J,358.4,124,0)
 ;;=CARDIOVASCULAR DISORDERS^1^16
 ;;^UTILITY(U,$J,358.4,125,0)
 ;;=CONDITIONS AFFECTING HEALTH CARE STATUS^2^16
 ;;^UTILITY(U,$J,358.4,126,0)
 ;;=DIABETES^4^16
 ;;^UTILITY(U,$J,358.4,127,0)
 ;;=EYE & EAR DISORDERS^4^16
 ;;^UTILITY(U,$J,358.4,128,0)
 ;;=MENTAL HEALTH^5^16
 ;;^UTILITY(U,$J,358.4,129,0)
 ;;=NEOPLASMS^6^16
 ;;^UTILITY(U,$J,358.4,130,0)
 ;;=NEUROLOGICAL CONDITIONS^7^16
 ;;^UTILITY(U,$J,358.4,131,0)
 ;;=OTHER CONDITIONS^8^16
 ;;^UTILITY(U,$J,358.4,132,0)
 ;;=RESPIRATORY DISORDERS^9^16
 ;;^UTILITY(U,$J,358.4,133,0)
 ;;=DEMENTIA^3^16
 ;;^UTILITY(U,$J,358.4,134,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^10^16
 ;;^UTILITY(U,$J,358.4,135,0)
 ;;=ASSESSMENT/COUNSELING^1^17
 ;;^UTILITY(U,$J,358.4,136,0)
 ;;=ONE ON ONE TRAINING^6^17
 ;;^UTILITY(U,$J,358.4,137,0)
 ;;=ED/GRP/FAMILY TRNG FOR SELF MGMT^2^17
 ;;^UTILITY(U,$J,358.4,138,0)
 ;;=TEAM CONFERENCE^8^17
 ;;^UTILITY(U,$J,358.4,139,0)
 ;;=HOME VISIT^5^17
 ;;^UTILITY(U,$J,358.4,140,0)
 ;;=IMPAIRMENT CODES^1^18
 ;;^UTILITY(U,$J,358.4,141,0)
 ;;=CONTRIBUTORY CONDITION^2^18
 ;;^UTILITY(U,$J,358.4,142,0)
 ;;=TBI-RELATED CONTRIB COND^5^18
 ;;^UTILITY(U,$J,358.4,143,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^4^18
 ;;^UTILITY(U,$J,358.4,144,0)
 ;;=FAMILY HX EYE CONDITIONS^3^18
 ;;^UTILITY(U,$J,358.4,145,0)
 ;;=NEW PATIENT^2^19
 ;;^UTILITY(U,$J,358.4,146,0)
 ;;=ESTABLISHED PATIENT^1^19
 ;;^UTILITY(U,$J,358.4,147,0)
 ;;=CONSULTATIONS^3^19
 ;;^UTILITY(U,$J,358.4,148,0)
 ;;=ARRHYTHMIA^3^20
 ;;^UTILITY(U,$J,358.4,149,0)
 ;;=CHEST PAIN^4^20
 ;;^UTILITY(U,$J,358.4,150,0)
 ;;=CHF/MYOPATHY/TRANSPLANT^5^20
 ;;^UTILITY(U,$J,358.4,151,0)
 ;;=CORONARY ATHEROSCLEROSIS^6^20
 ;;^UTILITY(U,$J,358.4,152,0)
 ;;=GENERAL SYMPTOMS^9^20
 ;;^UTILITY(U,$J,358.4,153,0)
 ;;=HISTORY^12^20
 ;;^UTILITY(U,$J,358.4,154,0)
 ;;=HYPERTENSION/HYPOTENSION^13^20
 ;;^UTILITY(U,$J,358.4,155,0)
 ;;=INFECTION/INFLM DISEASE^14^20
 ;;^UTILITY(U,$J,358.4,156,0)
 ;;=LIPID DISORDER^15^20
 ;;^UTILITY(U,$J,358.4,157,0)
 ;;=MYOCARDIAL INFARCTION^17^20
 ;;^UTILITY(U,$J,358.4,158,0)
 ;;=NONRHEUMATIC HEART VALVE DISORDERS^18^20
 ;;^UTILITY(U,$J,358.4,159,0)
 ;;=HEART DISEASE^10^20
 ;;^UTILITY(U,$J,358.4,160,0)
 ;;=HEART VALVE DISEASE^11^20
 ;;^UTILITY(U,$J,358.4,161,0)
 ;;=PERIPHERAL VASC DISEASE^20^20
 ;;^UTILITY(U,$J,358.4,162,0)
 ;;=RHEUMATIC HEART DISEASE^23^20
 ;;^UTILITY(U,$J,358.4,163,0)
 ;;=DEVICE/IMPLANT/GRAFT^7^20
 ;;^UTILITY(U,$J,358.4,164,0)
 ;;=SYNCOPE^26^20
 ;;^UTILITY(U,$J,358.4,165,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^24^20
 ;;^UTILITY(U,$J,358.4,166,0)
 ;;=ECTOPY^8^20
 ;;^UTILITY(U,$J,358.4,167,0)
 ;;=MISCELLANEOUS^16^20
 ;;^UTILITY(U,$J,358.4,168,0)
 ;;=VENTRICULAR ARRHYTHMIAS^27^20
 ;;^UTILITY(U,$J,358.4,169,0)
 ;;=SUPRAVENTRICULAR ARRHYTHMIAS^25^20
 ;;^UTILITY(U,$J,358.4,170,0)
 ;;=OTHER CARDIAC CONDITIONS^22^20
 ;;^UTILITY(U,$J,358.4,171,0)
 ;;=PULMONARY DISEASE^21^20
 ;;^UTILITY(U,$J,358.4,172,0)
 ;;=PACEMAKER/AIC/DEFIBRILLATOR^19^20
 ;;^UTILITY(U,$J,358.4,173,0)
 ;;=ACSC CHF^1^20
 ;;^UTILITY(U,$J,358.4,174,0)
 ;;=ACSC HYPERTENSION^2^20
 ;;^UTILITY(U,$J,358.4,175,0)
 ;;=PACEMAKER^15^21
 ;;^UTILITY(U,$J,358.4,176,0)
 ;;=CORONARY ANGIOPLASTY & STENTS^3^21
 ;;^UTILITY(U,$J,358.4,177,0)
 ;;=ELECTROPHYSIOLOGICAL PROCs^7^21
 ;;^UTILITY(U,$J,358.4,178,0)
 ;;=PERIPHERAL ANGIOPLASTIES & STENTS^16^21
 ;;^UTILITY(U,$J,358.4,179,0)
 ;;=VASCULAR INJECTION PROCs^21^21
 ;;^UTILITY(U,$J,358.4,180,0)
 ;;=OTHER PROCEDURES^14^21
 ;;^UTILITY(U,$J,358.4,181,0)
 ;;=HEART CATHETERIZATIONS^8^21
 ;;^UTILITY(U,$J,358.4,182,0)
 ;;=CATHETERIZATIONS FOR INT RADIOLOGY^2^21
 ;;^UTILITY(U,$J,358.4,183,0)
 ;;=OTHER HEART CODES^13^21
 ;;^UTILITY(U,$J,358.4,184,0)
 ;;=PROSTHETIC ANEURYSM REPAIR^19^21
 ;;^UTILITY(U,$J,358.4,185,0)
 ;;=DEVICE PROGRAMMING^4^21
 ;;^UTILITY(U,$J,358.4,186,0)
 ;;=ECHO^5^21
 ;;^UTILITY(U,$J,358.4,187,0)
 ;;=EKG^6^21
 ;;^UTILITY(U,$J,358.4,188,0)
 ;;=MEDICATION ADMINISTRATION^9^21
 ;;^UTILITY(U,$J,358.4,189,0)
 ;;=MEDICATIONS^10^21
 ;;^UTILITY(U,$J,358.4,190,0)
 ;;=OTHER CARDIAC^12^21
 ;;^UTILITY(U,$J,358.4,191,0)
 ;;=STRESS TESTS^20^21
 ;;^UTILITY(U,$J,358.4,192,0)
 ;;=PREVENTIVE COUNSELING^17^21
 ;;^UTILITY(U,$J,358.4,193,0)
 ;;=MODERATE SEDATION (MS)^11^21
 ;;^UTILITY(U,$J,358.4,194,0)
 ;;=VENTRICULAR ASSIST DEVICE INSERTION^22^21
 ;;^UTILITY(U,$J,358.4,195,0)
 ;;=CARDIOVERSION^1^21
 ;;^UTILITY(U,$J,358.4,196,0)
 ;;=PROLONGED SERVICES^18^21
 ;;^UTILITY(U,$J,358.4,197,0)
 ;;=NEW PATIENT^2^22
 ;;^UTILITY(U,$J,358.4,198,0)
 ;;=ESTABLISHED PATIENT^1^22
 ;;^UTILITY(U,$J,358.4,199,0)
 ;;=CONSULTATIONS^3^22
 ;;^UTILITY(U,$J,358.4,200,0)
 ;;=MISCELLANEOUS TREATMENT^4^23
 ;;^UTILITY(U,$J,358.4,201,0)
 ;;=CHIROPRACTIC MANIPULATIVE SERVICES^2^23
 ;;^UTILITY(U,$J,358.4,202,0)
 ;;=OSTEOPATHIC MANIPULATIVE TREATMENT^5^23
 ;;^UTILITY(U,$J,358.4,203,0)
 ;;=ACUPUNCTURE^1^23
 ;;^UTILITY(U,$J,358.4,204,0)
 ;;=EDUCATION FOR SELF MGT^3^23
 ;;^UTILITY(U,$J,358.4,205,0)
 ;;=EXTREMITIES/JOINTS/MUSCLES^6^24
 ;;^UTILITY(U,$J,358.4,206,0)
 ;;=HEAD AREA/NERVES^1^24
 ;;^UTILITY(U,$J,358.4,207,0)
 ;;=CERVICAL^2^24
 ;;^UTILITY(U,$J,358.4,208,0)
 ;;=THORACIC^3^24
 ;;^UTILITY(U,$J,358.4,209,0)
 ;;=LUMBAR^4^24
 ;;^UTILITY(U,$J,358.4,210,0)
 ;;=SACRUM^5^24
 ;;^UTILITY(U,$J,358.4,211,0)
 ;;=UNSPECIFIED^8^24
 ;;^UTILITY(U,$J,358.4,212,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^7^24
 ;;^UTILITY(U,$J,358.4,213,0)
 ;;=NEW PATIENT^1^25
 ;;^UTILITY(U,$J,358.4,214,0)
 ;;=ESTABLISHED PATIENT^2^25
 ;;^UTILITY(U,$J,358.4,215,0)
 ;;=EDUCATION & TRAINING FOR SELF MGMT^4^25
 ;;^UTILITY(U,$J,358.4,216,0)
 ;;=MEDICATION ADMIN^7^25
 ;;^UTILITY(U,$J,358.4,217,0)
 ;;=IMMUNIZATION ADMINISTRATION^5^25
 ;;^UTILITY(U,$J,358.4,218,0)
 ;;=IMMUNIZATIONS^6^25
 ;;^UTILITY(U,$J,358.4,219,0)
 ;;=CONTINUOUS GLUCOSE MONITORING^3^25
 ;;^UTILITY(U,$J,358.4,220,0)
 ;;=ANTICOAGULATION^2^26
 ;;^UTILITY(U,$J,358.4,221,0)
 ;;=PAIN^6^26
 ;;^UTILITY(U,$J,358.4,222,0)
 ;;=MENTAL HEALTH^5^26
 ;;^UTILITY(U,$J,358.4,223,0)
 ;;=ENDOCRINE^4^26
 ;;^UTILITY(U,$J,358.4,224,0)
 ;;=CARDIOVASCULAR^3^26
 ;;^UTILITY(U,$J,358.4,225,0)
 ;;=RESPIRATORY^7^26
 ;;^UTILITY(U,$J,358.4,226,0)
 ;;=OTHER^8^26
 ;;^UTILITY(U,$J,358.4,227,0)
 ;;=COMMON DIAGNOSIS^1^26
 ;;^UTILITY(U,$J,358.4,228,0)
 ;;=NEW PATIENT^3^27
 ;;^UTILITY(U,$J,358.4,229,0)
 ;;=ESTABLISHED PATIENT^1^27
 ;;^UTILITY(U,$J,358.4,230,0)
 ;;=CONSULTATIONS^2^27
 ;;^UTILITY(U,$J,358.4,231,0)
 ;;=PREVENTIVE MEDICINE-EST PT^4^27
 ;;^UTILITY(U,$J,358.4,232,0)
 ;;=PREVENTIVE MEDICINE-NEW PT^5^27
 ;;^UTILITY(U,$J,358.4,233,0)
 ;;=RISK FACTOR REDUCTION-GRP^6^27
 ;;^UTILITY(U,$J,358.4,234,0)
 ;;=RISK FACTOR REDUCTION-IND^7^27
 ;;^UTILITY(U,$J,358.4,235,0)
 ;;=OTHER^3^28
 ;;^UTILITY(U,$J,358.4,236,0)
 ;;=EDUCATION/TRAINING^1^28
 ;;^UTILITY(U,$J,358.4,237,0)
 ;;=MEDICAL NUTRITION THERAPY^2^28
 ;;^UTILITY(U,$J,358.4,238,0)
 ;;=WOUND TREATMENT^5^28
 ;;^UTILITY(U,$J,358.4,239,0)
 ;;=PROLONGED SERVICES^4^28
 ;;^UTILITY(U,$J,358.4,240,0)
 ;;=DIABETES^1^29
 ;;^UTILITY(U,$J,358.4,241,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^3^29
 ;;^UTILITY(U,$J,358.4,242,0)
 ;;=SOCIAL DETERMINANTS OF HEALTH^2^29
 ;;^UTILITY(U,$J,358.4,243,0)
 ;;=IMMUNIZATION^10^30
 ;;^UTILITY(U,$J,358.4,244,0)
 ;;=MEDICATION^13^30
 ;;^UTILITY(U,$J,358.4,245,0)
 ;;=ORTHO/JOINTS^6^30
 ;;^UTILITY(U,$J,358.4,246,0)
 ;;=RESPIRATORY SYSTEM^14^30
 ;;^UTILITY(U,$J,358.4,247,0)
 ;;=CRITICAL CARE/PULM/SEDATION^3^30
 ;;^UTILITY(U,$J,358.4,248,0)
 ;;=GI/GYN^7^30
 ;;^UTILITY(U,$J,358.4,249,0)
 ;;=NEURO/EYE/ENT^8^30
 ;;^UTILITY(U,$J,358.4,250,0)
 ;;=LACERATIONS^5^30
 ;;^UTILITY(U,$J,358.4,251,0)
 ;;=SKIN WOUNDS/BURNS^4^30
 ;;^UTILITY(U,$J,358.4,252,0)
 ;;=PSYCHIATRY^9^30
 ;;^UTILITY(U,$J,358.4,253,0)
 ;;=COMMON PROCEDURES^1^30
 ;;^UTILITY(U,$J,358.4,254,0)
 ;;=INFUSION/INJECTION ADMIN^11^30
 ;;^UTILITY(U,$J,358.4,255,0)
 ;;=ADDITIONAL VISIT CODES^2^30
 ;;^UTILITY(U,$J,358.4,256,0)
 ;;=COVID-19 RELATED^12^30
 ;;^UTILITY(U,$J,358.4,257,0)
 ;;=HEDIS CODE/MISC HCPCS^15^30
 ;;^UTILITY(U,$J,358.4,258,0)
 ;;=LABS PERFORMED IN ED^16^30
 ;;^UTILITY(U,$J,358.4,259,0)
 ;;=EMERGENCY DEPT VISIT^1^31
 ;;^UTILITY(U,$J,358.4,260,0)
 ;;=TRIAGE ONLY (NO MD SEEN)^4^31
 ;;^UTILITY(U,$J,358.4,261,0)
 ;;=ED OBS 1ST DAY-INIT^3^31
 ;;^UTILITY(U,$J,358.4,262,0)
 ;;=ED OBS (ADMIT&D/C SAME DAY)^2^31
 ;;^UTILITY(U,$J,358.4,263,0)
 ;;=ED COMMON DIAGNOSES^1^32
 ;;^UTILITY(U,$J,358.4,264,0)
 ;;=ADMINISTRATIVE TOPICS^2^32
 ;;^UTILITY(U,$J,358.4,265,0)
 ;;=CARDIOVASCULAR^3^32
 ;;^UTILITY(U,$J,358.4,266,0)
 ;;=EAR/NOSE/THROAT^6^32
 ;;^UTILITY(U,$J,358.4,267,0)
 ;;=ENDO/RENAL/ELECTROLYTES^5^32
 ;;^UTILITY(U,$J,358.4,268,0)
 ;;=EYE^7^32
 ;;^UTILITY(U,$J,358.4,269,0)
 ;;=GI/ABDOMEN^8^32
 ;;^UTILITY(U,$J,358.4,270,0)
 ;;=PSYCHIATRY^17^32
 ;;^UTILITY(U,$J,358.4,271,0)
 ;;=LACERATION(S)^16^32
 ;;^UTILITY(U,$J,358.4,272,0)
 ;;=PULMONARY^18^32
 ;;^UTILITY(U,$J,358.4,273,0)
 ;;=GU/RECTAL^9^32
 ;;^UTILITY(U,$J,358.4,274,0)
 ;;=HEME/ONC/VASCULAR^10^32
 ;;^UTILITY(U,$J,358.4,275,0)
 ;;=INFECTIOUS DISEASE^11^32
 ;;^UTILITY(U,$J,358.4,276,0)
 ;;=MUSCULOSKELETAL/MISC^14^32
 ;;^UTILITY(U,$J,358.4,277,0)
 ;;=NEUROLOGY^15^32
 ;;^UTILITY(U,$J,358.4,278,0)
 ;;=SKIN^19^32
 ;;^UTILITY(U,$J,358.4,279,0)
 ;;=MUSCULOSKELETAL-LE^12^32
 ;;^UTILITY(U,$J,358.4,280,0)
 ;;=MUSCULOSKELETAL-UE^13^32
 ;;^UTILITY(U,$J,358.4,281,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^21^32
 ;;^UTILITY(U,$J,358.4,282,0)
 ;;=E-CIG/VAPE LUNG INJURY (EVAL)^4^32
 ;;^UTILITY(U,$J,358.4,283,0)
 ;;=FALLS^22^32
 ;;^UTILITY(U,$J,358.4,284,0)
 ;;=VEHICLE ACCIDENTS^24^32
 ;;^UTILITY(U,$J,358.4,285,0)
 ;;=EXTERNAL CAUSES^26^32
 ;;^UTILITY(U,$J,358.4,286,0)
 ;;=PAIN^20^32
 ;;^UTILITY(U,$J,358.4,287,0)
 ;;=BITES-HUMAN/ANIMAL/INSECT^23^32
 ;;^UTILITY(U,$J,358.4,288,0)
 ;;=SUSPECTED COND R/O AFTER OBS^25^32
 ;;^UTILITY(U,$J,358.4,289,0)
 ;;=NEW PATIENT^2^33
 ;;^UTILITY(U,$J,358.4,290,0)
 ;;=ESTABLISHED PATIENT^1^33
 ;;^UTILITY(U,$J,358.4,291,0)
 ;;=CONSULTATIONS^3^33
 ;;^UTILITY(U,$J,358.4,292,0)
 ;;=ENDOCRINE DX^1^34
 ;;^UTILITY(U,$J,358.4,293,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^3^34
 ;;^UTILITY(U,$J,358.4,294,0)
 ;;=SOCIAL DETERMINANTS OF HEALTH^2^34
 ;;^UTILITY(U,$J,358.4,295,0)
 ;;=BIOPSIES^1^35
 ;;^UTILITY(U,$J,358.4,296,0)
 ;;=INJECTIONS & INFUSIONS^2^35
 ;;^UTILITY(U,$J,358.4,297,0)
 ;;=OTHER^4^35
 ;;^UTILITY(U,$J,358.4,298,0)
 ;;=PROLONGED CLINICAL STAFF SERVICES^5^35
 ;;^UTILITY(U,$J,358.4,299,0)
 ;;=LAB TESTS^3^35
 ;;^UTILITY(U,$J,358.4,300,0)
 ;;=TEST - CATARACT / COLOR^4^36
 ;;^UTILITY(U,$J,358.4,301,0)
 ;;=IMAGING / PHOTOS^2^36
 ;;^UTILITY(U,$J,358.4,302,0)
 ;;=TEST - GLAUCOMA^3^36
 ;;^UTILITY(U,$J,358.4,303,0)
 ;;=TEST - OTHER^5^36
 ;;^UTILITY(U,$J,358.4,304,0)
 ;;=REFRACT / GLASSES / CL^1^36
 ;;^UTILITY(U,$J,358.4,305,0)
 ;;=EEF Version 2022 July^6^36
 ;;^UTILITY(U,$J,358.4,306,0)
 ;;=LOW VISION / BLINDNESS^21^37
 ;;^UTILITY(U,$J,358.4,307,0)
 ;;=RETINA - VASCULAR^12^37
 ;;^UTILITY(U,$J,358.4,308,0)
 ;;=EYELIDS / LASHES^2^37
 ;;^UTILITY(U,$J,358.4,309,0)
 ;;=NEURO / STRABISMUS^18^37
 ;;^UTILITY(U,$J,358.4,310,0)
 ;;=ORBIT - PLASTICS^20^37
 ;;^UTILITY(U,$J,358.4,311,0)
 ;;=VITREOUS^17^37
 ;;^UTILITY(U,$J,358.4,312,0)
 ;;=ORBIT - TRAUMA^19^37
 ;;^UTILITY(U,$J,358.4,313,0)
 ;;=LACRIMAL / NLD / NEOPLASMS^3^37
 ;;^UTILITY(U,$J,358.4,314,0)
 ;;=MOST FREQUENT^1^37
 ;;^UTILITY(U,$J,358.4,315,0)
 ;;=CONJUNCTIVA / SCLERA^4^37
 ;;^UTILITY(U,$J,358.4,316,0)
 ;;=CORNEA / ULCER^5^37
 ;;^UTILITY(U,$J,358.4,317,0)
 ;;=LENS / CATARACT / POSTOP^6^37
 ;;^UTILITY(U,$J,358.4,318,0)
 ;;=IRIS / UVEITIS^7^37
 ;;^UTILITY(U,$J,358.4,319,0)
 ;;=GLAUCOMA - OPEN ANGLE^8^37
 ;;^UTILITY(U,$J,358.4,320,0)
 ;;=GLAUCOMA - CLOSED ANGLE^9^37
 ;;^UTILITY(U,$J,358.4,321,0)
 ;;=GLAUCOMA - SECONDARY^10^37
 ;;^UTILITY(U,$J,358.4,322,0)
 ;;=RETINA - CHOROID / TUMORS / INFLAM^14^37
 ;;^UTILITY(U,$J,358.4,323,0)
 ;;=RETINA - TEAR / PERIPH / DEGENERATION^15^37
 ;;^UTILITY(U,$J,358.4,324,0)
 ;;=RETINA - MACULA^11^37
 ;;^UTILITY(U,$J,358.4,325,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^23^37
